Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2005 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
The following term was not found in PubMed: /
Page 1
High-dose therapy with ropinirole in patients with Parkinson's disease.
Müngersdorf M, Sommer U, Sommer M, Reichmann H. Müngersdorf M, et al. J Neural Transm (Vienna). 2001;108(11):1309-17. doi: 10.1007/s007020100007. J Neural Transm (Vienna). 2001. PMID: 11768629 Clinical Trial.
Ropinirole is effective as mono- and combination therapy in PD. Previous studies have used a maximal dose of 24 mg/day; the present study assesses the effect of higher doses (up to 36 mg/day) on patients with motor fluctuations. ...The mean levodopa dose fell by 32% during …
Ropinirole is effective as mono- and combination therapy in PD. Previous studies have used a maximal dose of 24 mg/day; the present s …
[Practical experience on improving activities of daily living competence in Parkinson's patients treated with ropinirole. Results of a applied study].
Reichmann H, Angersbach D, Buchwald B. Reichmann H, et al. Nervenarzt. 2005 Oct;76(10):1239-40, 1242-5. doi: 10.1007/s00115-005-1957-y. Nervenarzt. 2005. PMID: 16003527 Clinical Trial. German.
Ropinirole is a non-ergot-selective D2 dopamine agonist. Its efficacy, tolerability, and safety have been extensively proven in controlled, double-blind trials. ...The results of this postmarketing study corroborate the good clinical efficacy of ropinirole together …
Ropinirole is a non-ergot-selective D2 dopamine agonist. Its efficacy, tolerability, and safety have been extensively proven in contr …
[1st long-term double-blind study of effectiveness and dyskinesia prevention of ropinirol].
Reichmann H, Lachenmayer L. Reichmann H, et al. Nervenarzt. 2000 Dec;71(12):1012-4. doi: 10.1007/s001150050701. Nervenarzt. 2000. PMID: 11139984 Clinical Trial. German.
In this paper, we discuss the reasons for these recommendations, which are based on the findings of the first double-blinded study in which L-dopa was compared with ropinirole, a nonergot dopamine agonist, over a 5-year period. The main results of this study are as follows …
In this paper, we discuss the reasons for these recommendations, which are based on the findings of the first double-blinded study in which …